CIK 0001842952 · <br>Emerging growth company
Context Therapeutics Inc.
Sign in to watch- Ticker
- CNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863738787
- Phone
- 267-225-7416
- Business address
- 2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, 19103
- Former names
- Context Therapeutics LLC
- 3/A Insider 3/A
- 3/A Insider 3/A
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market buy Chief Legal Officer, Corp. Sec bought 3,000 shares at $5.00 ($15,000)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at $5.00 ($50,000)
- 4 Conversion SVP of R&D acquired 26,587 shares (conversion)
- 8-K Event Executive or director change · Bylaws or fiscal year change · Other events
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 13 of 16 · 309 filings